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The purpose of this study was to evaluate effects of a low-glycemic index diet 
on weight, body mass index (BMI), triglycerides, cholesterol levels, and hemoglobin A1c 
(HbA1c) following participation in a 12-hour outpatient diabetes self-
management education (DSME) program.  This DSME program is unique as it 
focuses on a low-glycemic index diet rather than the traditional carbohydrate consistent 
diet to control blood glucose levels. Health outcomes obtained post participation were 
compared to baseline data. Participants were 283 individuals with type 2 diabetes 
including 94 (33%) men and 189 (67%) women, with a mean baseline HbA1c of 8.7 
±2.2%. Statistically significant improvements were seen in mean BMI (-0.7±2.0 kg/m2, 
p<0.05), HbA1c (-1.1±1.9%, p<0.05), and total cholesterol (-12.3±37.3 mg/dL, 
p<0.05). No statistically significant differences in changes between men and women were 
found for the outcomes measured. Although males showed improvements in HDL 
cholesterol  (+1.7±8.1 mg/dL, p =0.052), results were not statistically significant, unlike 
the significant improvements for the female group (+1.6±10.1 mg/dL, p<0.05). 
Traditionally, a carbohydrate consistent diet has been supported as the primary diet for 
diabetes management. This research shows a low-glycemic index diet can also be 
beneficial. Future research should include long-term randomized control trials to compare 
the two approaches to diabetes management. The effects of the low-glycemic index diet 
on medication use and quality of life also should be explored. 
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According to the American Diabetes Association (ADA), diabetes is characterized 
by hyperglycemia triggered by an abnormal surge in insulin and/or a defect in insulin 
action (2014). The development of diabetes can be caused by autoimmune damage to 
pancreatic B-cells, promoting an insulin deficiency and defects in tissue insulin 
sensitivity. Often, diminishing insulin secretion and insulin resistance can occur 
simultaneously in the same individual, and it can be unclear which defect is the primary 
cause of hyperglycemia (ADA, 2014). 
Two general etiopathogenetic groups, Type 1 and Type 2 diabetes, categorize the 
majority of diabetes cases (ADA, 2014).  Individuals diagnosed with type 1 diabetes have 
the inability to secrete insulin (ADA, 2014). On the other hand, individuals with both 
insulin resistance and insufficient compensatory insulin secretory response are 
categorized as having type 2 diabetes (ADA, 2014). 
 
Statement of the Problem 
 
The evidence highlighting the prevalence and incidence of diabetes is astounding. 
The 2017 National Diabetes Statistic Report indicates that of the 30.3 million people who 
have diabetes, 23.1 million have been formally diagnosed by a physician (Centers for 
Disease Control and Prevention, 2017). According to the Centers for Disease Control and 
Prevention’s (CDC) 2016 Diabetes Data and Statistics report, Louisiana has the 5th 
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highest diabetes rate in the United States, with 11.8% of adults having a diagnosis of 
diabetes. If not managed properly, diabetes can lead to a number of complications. 
Common long-term complications from chronic hyperglycemia of diabetes include 
retinopathy, nephropathy, peripheral neuropathy, and autonomic neuropathy (ADA, 
2014). Individuals with diabetes also have an increased risk for atherosclerotic 
cardiovascular, peripheral arterial, and cerebrovascular disease, as well as hypertension 
and lipoprotein metabolism abnormalities (ADA, 2014). These complications generally 
are associated with reduced life expectancy and decreased quality of life (ADA, 2014). 
Numerous healthcare programs and services are available for individuals with 
diabetes to help manage their condition (Bianconi, Pope, Erickson, & Hood, 2016; Evert, 
Boucher, & Cypress, 2013; Franz, Boucher, & Evert, 2014; Franz, MacLeod, & Evert, 
2017; Hall, Strong, & Krebs, 2016; Marincic, Hardin, & Salazae, 2017; Pastors & Franz, 
2012). BRG Fit! is a 12-hour outpatient diabetes management program offered at Baton 
Rouge General (BRG) Medical Center in Baton Rouge, Louisiana.  The program focuses 
on using a low-glycemic index diet to control blood glucose levels, and is accredited by 
the American Association of Diabetes Educators (AADE) and the ADA. Participants can 
either enroll themselves in the program or their physician can refer them. Referral is not 
limited to BRG physicians. Physicians refer patients with newly diagnosed diabetes and 
those with a previous diagnosis of diabetes. This program offers three, 3-hour group 
sessions, which focus on disease management, nutrition, and chronic complications 
associated with diabetes. All three group sessions are offered once a month, so 
participants begin the program as they are referred. A Registered Nurse (RN) leads the 
disease management and chronic complications group session, while a Registered 
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Dietitian (RD) leads the nutrition session. The instructors and learning materials are 
consistent for all participants. All participants are provided a hard copy of the program 
learning materials to take home and review, even if they are not able to fully complete all 
12 hours of the program. The program also offers one 1-hour individual counseling 
session with the RN, and two 1-hour individual counseling sessions with the RD. Group 
sessions and individual counseling sessions are scheduled according to the participant’s 
personal schedule. Depending on the insurance policies of participants, coverage and 
participation for these sessions vary. BRG Fit! does not offer exercise classes, but 
physical activity goals are set during the individual counseling sessions with the RD. An 
annual follow-up is provided following participation in the 12-hour program. However, 
some patients are seen more often seen more than others. The number of follow-up 
sessions between the initial visit and the annual follow-up session is typically dependent 
on an individuals’ needs, compliance, insurance coverage, and ability to pay. On the 
initial visit, demographics, height, weight, and waist circumference are measured and 
recorded by either the RD or RN. Participants provide records of their most recent blood 
chemistry panels including triglycerides, hemoglobin A1c, total cholesterol, high-density 
lipoprotein (HDL) cholesterol, and low-density lipoprotein (LDL) cholesterol for the RN 
and RD to review.  
The BRG Fit! is a unique program that recommends a low-glycemic index diet in 
an attempt to reduce the body’s insulin response and control blood glucose levels. BRG 
Fit! recommends 8-12 cups of water per day, with water being the primary beverage. 
Sugar sweetened beverages, artificial sweeteners, sugar substitutes, and juices are 
avoided. Protein, fat, and fiber are recommended as the focus of each meal and snack. 
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BRG Fit! promotes animal based protein sources from poultry, pork, beef, seafood, 
cheese, and whole eggs, while breaded and/or fried meats are avoided. According to BRG 
Fit!, fats such as olive oil, coconut oil, nut oils, nuts, nut butters, and seeds are 
recommended to properly absorb fat-soluble vitamins. Butter is recommended over 
margarine, and vegetable oil, soybean oil, and canola oil are avoided. Fresh or frozen 
whole fruits and vegetables, milk, yogurt, and legumes are considered nutrient-dense 
carbohydrates and are allowed. All grains, added sugars, and starches are avoided in an 
attempt to control blood glucose levels. The following grains are to be avoided: any 
variety of rice and wheat, corn, quinoa, oats, popcorn, grits, potatoes, and others. BRG 
Fit! also promotes reading ingredient lists, and suggests that a food product should not be 
consumed if the ingredient list is long or if the participant cannot pronounce or identify 
an ingredient (Baton Rouge General Medical Center, 2015).  
Current research focusing on low-glycemic approaches to diabetes management is 
limited. One study found individuals with type 2 diabetes improved glycemic control and 
lost more weight after participation in a randomized online low-carbohydrate, ketogenic 
diet program designed to compare results to those who were randomly assigned to a 
traditional, low-fat diabetic diet recommended by the ADA (Saslow, Mason, & Kim, 
2017). Another recent study found a 6-month diet of less than 130 grams of 
carbohydrates per day reduced HbA1c and Body Mass Index (BMI) more than when 
compared to a calorie restricted diet. However, a one-year follow-up study showed the 
benefits of the low-carbohydrate diet on BMI and HbA1c did not persist in comparison 
with the calorie-restricted diet (Santo et al., 2017). Additional research is necessary to 
evaluate the effects of a low-glycemic diet in improving glycemic control. The BRG Fit! 
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diabetes management program has been in existence since 2012. Though health care 
providers have seen success, the program has not been formally evaluated.  
 
 
Purpose of the Study 
 
The purpose of this study was to identify differences in weight, BMI, 
triglycerides, cholesterol levels, and hemoglobin A1c values following participation in a 
12-hour outpatient diabetes management program focused on using a low-glycemic index 
diet to control blood glucose levels. Health outcomes obtained one year following 
program participation were compared to baseline data obtained prior to beginning the 




Three hypotheses were tested: 
1. There will be no significant difference in BMI and weight from baseline and 
measures obtained at the 1-year follow-up. 
 
2.  There will be no significant difference in hemoglobin A1c values, cholesterol levels, 
and triglyceride levels from baseline and measures obtained at the 1-year follow-up. 
 
3. There will be no significant difference in the change in hemoglobin A1c values, 
cholesterol levels, and triglyceride levels from baseline to measures obtained at the1-
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Justification 
 
Numerous healthcare programs and services are available for people with diabetes 
to learn how to manage their condition (Bianconi et al., 2016; Evert et al., 2013; Franz et 
al., 2014; Franz et al., 2017; Hall et al., 2016; Marincic et al., 2017; Pastors & Franz, 
2012).  Significant components of many programs are nutrition education and counseling 
provided by Registered Dietitians (RDs). Registered Dietitians have been trained to teach 
diabetic patients how to use different dietary strategies and physical activity to control 
their blood glucose levels and therefore manage their disease state (Mitchell et al., 2017). 
According to a 2017 systemic review of randomized control trials, adults counseled by 
RDs have shown improvement in diet quality; diabetes outcomes, such as blood glucose 
and hemoglobin A1c values; and weight loss outcomes, such as changes in weight and 
waist circumference (Mitchell et al., 2017). However, evidence specifically surrounding 
outcomes of low-glycemic interventions in the outpatient setting is limited.  
The aim of this study was to evaluate the anthropometric and biochemical 
outcomes of patients who have participated in BRG Fit!, a 12-hour outpatient diabetes 
management program focused on a low-glycemic index diet. The results of this study will 
provide great benefit to Baton Rouge General Medical Center. If results are positive, 
BRG could use these results to attract more patients and increase business by 
demonstrating program success in managing diabetes. Positive program outcomes may be 
used to attract additional referrals and patient participation, thereby increasing revenue.  
Additional program participants may assist BRG in receiving additional reimbursement 
for services and offering the hospital opportunities to enhance the medical services 
provided. Positive research results would also enable the program manager and staff an 
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opportunity to demonstrate a viable transition in patients from inpatient care to outpatient 
care services, thereby enhancing the continuity of care and promoting better disease 
management and prevention. In addition, positive results may provide evidence that a 
low-glycemic diet can be an effective strategy for diabetes management. This evidence 
also could be used in the development of future standardized diabetes management 
strategies. Negative outcomes also may be beneficial for BRG, as they can provide 
insight into where improvement and development is needed. The results of this study will 
provide insight for peers, health professionals, and future nutrition-related program 
planning.






REVIEW OF LITERATURE  
 
 
According to the American Diabetes Association (ADA), diabetes is defined as a 
group of metabolic diseases specifically classified by hyperglycemia, which results from 
either failure in insulin secretion or insulin action (ADA, 2014).  Occasionally, insulin 
secretion and insulin action defects can occur in the same individual (ADA, 2014). The 
number of people with diabetes is steadily increasing among both genders and all age and 
ethnicity population groups (ADA, 2014). 
 
Prevalence of Diabetes 
 
The 2017 National Diabetes Statistic Report indicates of the 30.3 million people 
who have diabetes, 23.1 million have been formally diagnosed with diabetes by a 
physician (Centers for Disease Control and Prevention, 2017). Since 1958, the prevalence 
of diabetes among US citizens has significantly increased.  Nearly 60 years ago, 1.58 
million people or 0.93% of the U.S. population were diagnosed with diabetes (Centers for 
Disease Control & Prevention, 2017). Over a span of nearly 60 years the prevalence of 
diabetes has increased roughly ten-fold. 
The prevalence of diabetes is increasing worldwide, and it is especially prevalent 
in the United States. According to the Centers for Disease Control (CDC) and Prevention, 
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diabetes affects people of all ages, ethnicities, socioeconomic levels and genders and is 
also widespread across all geographical regions. The percentage of adults with diabetes is 
shown to increase as a part of the aging process, with 25.2% of those aged 65 years or 
older being diagnosed with diabetes (Centers for Disease Control and Prevention, 2017). 
The highest prevalence of diabetes for both men (14.9%) and women (15.3%) is seen in 
American Indians/Alaskan Natives (Centers for Disease Control and Prevention, 2017).  
Overall, prevalence is higher among American Indians/Alaskan Natives (15.1%), non-
Hispanic blacks (12.7%), and people of Hispanic ethnicity (12.1%) than among non-
Hispanic whites (7.4%) and Asians (8.0%) (Centers for Disease Control and Prevention, 
2017). Prevalence also varied significantly by level of education, which is often an 
indicator of socioeconomic class (Centers for Disease Control and Prevention, 2017). The 
highest prevalence was seen in those with less than a high school education (12.6%) 
compared to those with a high school education (9.5%) and those with more than a high 
school education (7.2%) (Centers for Disease Control and Prevention, 2017).  
Individuals living in the Southern and Appalachian regions of the United States 
tended to have the highest prevalence of diagnosed diabetes (Centers for Disease Control 
and Prevention, 2017). According to the CDC’s 2016 Diabetes Data and Statistics report, 
Louisiana has the 5th highest diabetes rate in the United States, with 11.8% of the adult 
population having a diagnosis of diabetes.  However, the ADA reported the prevalence of 
diabetes among adults living in Louisiana is actually higher than 11.8%. According to the 
ADA, 13.9% or 521,294 Louisiana residents had diabetes in 2015 (ADA, 2015). 
 
 




Diagnostic Criteria for Diabetes 
 
Indicators for determining increased risk for diabetes development or pre-diabetes 
include a fasting plasma glucose (FPG) from 100 mg/dL to 125 mg/dL, a 2-hour 
postprandial glucose (PG) test in the oral glucose tolerance test (OGTT) from 140 mg/dL 
to 199 mg/dL, or Hemoglobin A1c (HbA1c) of 5.7-6.4% (Cefalu, Bakris, & Blonde, 
2017). An OGTT uses a glucose load containing the equivalent of 75 grams of anhydrous 
glucose dissolved in water. For FPG, fasting is defined as no caloric intake for at least 
eight hours prior to testing. Criteria for diagnosing diabetes include HbA1c values > 
6.5%, FPG > 126 mg/dL, 2-hour PG test > 200 mg/dL during an OGTT, or a random 
plasma glucose > 200 mg/dL in patients exhibiting classic symptoms of hyperglycemia or 
hyperglycemic crisis. Classic symptoms characterizing hyperglycemia include polyuria, 
polydipsia, weight loss, polyphagia, and blurred vision (ADA, 2019).   
 
Complications of Diabetes 
 
The effects of chronic hyperglycemia of diabetes have been associated with long-
term damage, dysfunction, and failure of varying organs (Cefalu et al., 2017).  The 
organs most commonly affected by chronic hyperglycemia are the eyes, kidneys, nerves, 
heart, and blood vessels. Long-term consequences of diabetes commonly include 
retinopathy causing possible loss of vision; nephropathy resulting in renal failure; 
peripheral neuropathy increasing risk for foot ulcers, amputations and Charcot joints; and 
autonomic neuropathy with gastrointestinal, genitourinary, and cardiovascular symptoms. 
Increased incidence of atherosclerotic cardiovascular, peripheral arterial and cerebral 
disease is commonly seen in individuals with diabetes. Individuals with diabetes also 
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commonly have hypertension and defects in lipoprotein metabolism. Moreover, chronic 
hyperglycemia is also associated with growth impairment and susceptibility to certain 
infections. Hyperglycemia with ketoacidosis and non-ketotic hyperosmolar syndrome are 
acute consequences of uncontrolled diabetes that can be fatal. Therefore, all individuals 
with diabetes should receive nutrition education and develop glucose monitoring skills to 
learn how to properly manage diabetes in order to reduce the risk of developing 
complications (Cefalu et al., 2017). 
 
Effectiveness of Nutrition Therapy in Diabetes Management 
 
As the prevalence of diabetes continues to rise, effective dietary strategies are a 
necessary component of diabetes management programs (Hall, Strong, & Krebs, 2016). 
Three central components of diabetes management include weight loss or weight 
maintenance, improving glycemic control, and prevention or reduction in risk associated 
with uncontrolled diabetes (Hall et al., 2016). Dietary strategies such as carbohydrate 
counting and timing of meals with medications have traditionally been used as the best 
practices for assisting individuals with diabetes to obtain optimum blood glucose control 
(Hall et al., 2016).  
Current research provides evidence that nutrition therapy for diabetes is effective 
in improving overall glycemic control and other metabolic outcomes (Franz et al., 2017). 
Hemoglobin A1c (HbA1c) is widely used to assess overall glycemic control because it 
demonstrates how effective the individuals were in controlling their blood glucose levels 
over a three month period of time (Franz et al., 2014).  Nutrition therapy provided by 
RDs has been successful in decreasing HbA1c levels by an average of 1% to 2% 
depending on the type and extent of diabetes and initial HbA1c levels (Academy of 
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Nutrition and Dietetics, 2015; Evert et al., 2013; Franz et al., 2010; Pastors & Franz, 
2012). For instance, individuals with newly diagnosed diabetes and an initial HbA1c 
level of roughly 9% experienced a reduction of about 2% following nutrition therapy 
intervention, while newly diagnosed individuals with roughly 6.6% HbA1c levels 
experienced a 0.4% decrease (Andrews et al., 2011; UK Prospective Diabetes Study, 
1990). Both results prove to be significant and clinically momentous. Patients diagnosed 
with diabetes for greater than nine years experienced about a 5% decrease in HbA1c 
levels following use of nutrition therapy intervention (Coppell et al., 2010). A reduction 
in HbA1c levels has been demonstrated to be more cost-effective than using additional 
medications (Coppell et al., 2010). Medical nutrition therapy that has focused on 
modifying insulin doses based on carbohydrate intake in patients with type 1 diabetes 
resulted in about a 1% decrease in HbA1c levels, and enhanced quality of life without 
increasing hypoglycemia or cardiovascular risks (DAFNE Study Group, 2002). 
Additional research has supported these results by demonstrating similar findings as well 
as other beneficial outcomes, which include weight loss, decreased blood pressure, 
improved lipid profiles, decreased need for medication, and decreased risk for 
development of diabetes-related complications (Pastors & Franz, 2012).  
A recent retrospective chart review examined the outcomes of a diabetes self-
management education and medical nutrition therapy program (Marincic et al., 2017). 
The program consisted of 8.5 hours of group classes, and 1.5 hours of individualized 
counseling with an RD. The duration of this program was approximately four months. 
This program focused on traditional carbohydrate counting and heart healthy eating 
methods. From baseline, significant weight loss (-1.6 kg±3.9, p=0.001) was observed. 
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Significant HbA1c reduction (-1.92%±2.25%, p=0.001) was observed from baseline, with 
72% of patients reaching HbA1c goals. Triglycerides were reduced, and HDL cholesterol 
increased from baseline (Marincic et al., 2017). Another recent retrospective study 
evaluated the effectiveness of a diabetes education program in improving HbA1c values 
in 162 United States Military veterans (Bianconi et al., 2016). HbA1c values were 
significantly lower following program participation compared to baseline. However, no 
significant differences were found in the participants’ HbA1c values based on the number 
of classes attended or BMI at baseline (Bianconi et al., 2016).  It is well accepted that 
outpatient diabetes intervention is an effective strategy in improving glycemic control 
(Academy of Nutrition and Dietetics, 2015; Andrews et al., 2011; Bianconi et al., 2016; 
Coppell et al., 2010; DAFNE Study Group, 2002; Evert et al., 2013; Franz et al., 2010; 
Hall et al., 2016; Marincic et al., 2107; Pastors & Franz, 2012; UK Prospective Diabetes 
Study, 1990).  
Nutrition Therapy Interventions  
 
Nutrition therapy interventions traditionally used by registered dietitians include 
carbohydrate counting, individualized meal plans, calorie and fat intake reduction, 
insulin-to-carbohydrate ratios, exchange lists, physical activity, and behavioral strategies 
(Franz et al., 2014).  Based on the ADA recommendations, individuals with diabetes 
should receive individualized nutrition therapy provided by a competent registered 
dietitian, who is able to provide diabetes medical nutrition therapy (Evert et al., 2013). In 
turn, the patient will be better able to reach treatment goals and glycemic control. One 
study compared the effects of four diabetes self-management education (DSME) 
programs (Dirlam, Pope, Erickson, & Fontenot, 2017). The four programs compared 
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were: a DSME program taught by a RD; a multidisciplinary DSME course; a single-
session diabetes education course taught by an RD that involved peer teaching; and 
individualized MNT taught by an RD. All four groups were successful in decreasing 
HbA1c (x̄ =− 1.87±0.49%) and no method was significantly more effective than another. 
All four methods were also effective in lowering LDL cholesterol (x̄ =25±15 mg/dL), 
although the DSME program led by an RD had the most significant improvement, with a 
mean decrease of 49±79 mg/dL. None of the methods were successful in producing a 
significant body weight change. The results suggest that any form of diabetes education 
can be effective in decreasing HbA1c and LDL (Dirlam et al., 2017). In another recent 
study, the effects of a single individual diabetes education session were compared to the 
effects of a group program on HbA1c and lipids in individuals with type 2 diabetes 
(Haque, Hoster, & Mistry, 2017). There were no significant differences between the 
groups for HbA1c or lipid values. However, clinically significant differences were noted 
from pre- to post- intervention in HbA1c and lipid values in participants completing the 
group program (Haque et al., 2017). Additional evidence also shows multiple counseling 
sessions with an RD and yearly follow-up visits are important for optimum medical 
management and health outcomes (Evert et al., 2013; Franz et al., 2014; Pastors & Franz, 
2012).  
Prevalence of Nutrition Therapy  
 
Nutrition therapy for diabetes is effective in improving overall glycemic control 
and other metabolic outcomes (Franz et al., 2014). However, nationally representative 
data suggest that only half of individuals with diabetes ever receive diabetes education, 
and less visit a registered dietitian (Ali et al., 2013). Additionally, one study including 
	   	   	  
	  
15 
over 18,000 individuals with diabetes found only 9.1% of participants received at least 
one nutrition therapy session over the course of nine years (Robbins, Thatcher, Webb, & 
Valdmanis, 2008). Diabetes care components necessary for improved outcomes include 
diabetes self-management, on-going support, and nutrition therapy (Franz et al., 2014).  
 
Weight Loss Intervention and Glycemic Control 
 
Achieving and maintaining a healthy body weight is a primary strategy for 
improving glycemic control (Bantle et al., 2008). Weight loss interventions for 
individuals newly diagnosed with diabetes have been shown to be specifically beneficial 
in improving glycemic control (Esposito et al., 2009; Feldstein et al., 2008).  
However, the benefit of weight loss intervention among diabetics is controversial 
(Franz, 2013). According to the Academy of Nutrition and Dietetics, only half of weight 
loss studies in individuals with type 2 diabetes produced reduction in HbA1c levels one 
year post-intervention (Franz et al., 2010). Weight loss intervention studies lasting one 
year or longer among individuals with type 2 diabetes showed weight loss ranged from 
1.9 kg to 8.4 kg (Evert et al., 2013). The Mediterranean-style diet and the intensive life 
style intervention in the Look AHEAD (Action for Health in Diabetes) trial were two 
interventions that resulted in the largest amount of weight loss after one year in newly 
diagnosed individuals. Individuals following a Mediterranean-style diet had a weight loss 
of 6.2 kg to 8.4 kg while participants in the Look AHEAD trial had a weight loss from 
baseline of 6% in the intervention group and 3.5% in the control group (Esposito et al., 
2009; Pi-Sunyer et al., 2007). A weight loss of > 6 kg (approximately 7-8.5% of initial 
body weight), regular physical activity, and frequent contact with RDs appear important 
for consistent beneficial effects of weight loss interventions (Franz et al., 2007). Half of 
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the intervention groups studied by the ADA reduced HbA1c levels at one year, while the 
other half did not incur any significant changes in HbA1c levels (Evert et al., 2013). Lipid 
panels and blood pressure outcomes from the weight loss interventions varied (Evert et 
al., 2013).   
Most of the ADA reviewed weight loss interventions produced a weight loss 
ranging from 1.9 kg to 4.8 kg in overweight or obese individuals with type 2 diabetes 
following one year of intervention; however, this weight loss was less than 5% of 
baseline weight (Evert et al., 2013).  Despite the fact that patients did not achieve the 
expected weight loss goal, the patients did show improvements in HbA1c levels, lipid 
panels, and blood pressures; but, improvements did not provide consistent results (Evert 
et al., 2013).  Interestingly, research suggests weight loss may be more challenging for 
individuals with diabetes (Franz et al., 2007). According to a systemic review of 80 
studies including 26,000 participants, the average weight loss is reported to be about 7.5 
kg or 8% of baseline weight (Franz et al., 2007).   
Consequently, weight loss intervention with the goal of improved glycemic 
control may be most beneficial for individuals with prediabetes or those newly diagnosed 
(Franz et al., 2014). Regular visits with a registered dietitian, consistent physical activity, 
and a 7-8.5% loss of initial body weight seem to be crucial for positive effects on 
glycemic control, lipids, and blood pressure (Franz, 2013). Nutrition therapy goals are not 
limited strictly to weight loss. Nutrient-dense intake, regular physical activity, and 
supportive behavioral changes are recommended for individuals with type 2 diabetes 
(Franz et al., 2014). 
 




Low-Glycemic Diet in Diabetes Management 
 
Over the years, researchers have used a number of different diet regimens with 
varying macronutrient percentage combinations to assess the effectiveness in controlling 
blood glucose levels and/or promoting weight loss among individuals with diabetes. At 
this time, there is considerable debate regarding the one diet regimen that is most 
effective (Franz et al., 2010; Franz et al., 2014; Hall et al., 2016; MacLeod, Franz, & 
Handu, 2017; Oza-Frank, Cheng, Narayan, & Gregg, 2009). According to one study, the 
majority of individuals with diabetes in the U.S. consume approximately 45% of total 
energy intake from carbohydrates, 35-40% from fat, and the remainder from protein 
(Oza-Frank et al., 2009).  Positive results have been shown with an emphasis on total 
energy intake rather the energy source (Franz et al., 2010). However, the changes each 
individual with diabetes is willing and able to make have been found to alter total energy 
intake, which makes individualization crucial (Franz et al., 2010).  Individualization goes 
beyond determining specific energy needs. Diet individualization is important for 
diabetic patients to reach metabolic goals while staying true to their personal preferences, 
culture, tradition, religion, and health benefits to promote compliance with disease 
management (Franz et al., 2010). 
A considerable amount of debate surrounds the various types of carbohydrates, 
particularly the function of the glycemic index (GI) and glycemic load (GL) (Franz et al., 
2014). The GL is based on portion sizes. The GI is a ranking system to measure the level 
at which a carbohydrate containing food raises the blood glucose level. This ranking 
system uses white bread with a GI of 100 to compare all other carbohydrate containing 
foods’ impact on the blood glucose level. However, a recent study evaluating the 
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reliability of the GI for white bread following ingestion by healthy adults found 
considerable influence based on the participant’s age, BMI, serum triglycerides, insulin 
index, and HbA1c, among other factors (Matthan, Ausman, Meng, Tighiouart, & 
Lichtenstein, 2016). In order to determine the GI of a food, individuals consume 50 
grams of the carbohydrate food being tested and a control food (Academy of Nutrition 
and Dietetics, 2017). The control food contains the same amount of carbohydrate as the 
test food. Blood glucose samples are collected prior to carbohydrate consumption, and 
then at regular intervals following consumption. The blood glucose changes throughout 
the test are plotted as a curve. The GI characterizes the qualified area below the glucose 
curve (Academy of Nutrition and Dietetics, 2017). The general public often receives 
misinformation, which sometimes defines GI as measuring how quickly blood glucose 
levels increase following consumption of a specific carbohydrate-containing food (Franz 
et al., 2014).  This piece of misinformation suggests that high-GI foods cause a rapid, 
high glucose peak, and low-GI food causes a more steady and continued glucose reaction 
(Franz et al., 2014).  The GL compares the potential of foods containing the same amount 
of carbohydrate to raise blood glucose levels, and is used to describe the quality and 
quantity of carbohydrate in a food serving, meal or diet (Academy of Nutrition and 
Dietetics, 2017). 
A review of studies comparing the glucose reactions of low-GI and high-GI foods 
showed glucose peaked at about 30 minutes despite being labeled a high-GI, medium-GI, 
or low-GI food (Brand-Miller, Stockmann, Atkinson, Petocz, & Denyer, 2009).  Because 
of the insignificant difference in peak glucose values of low- and high-GI foods, 
researchers decided that high-GI foods do not cause a more rapid peak in blood glucose 
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nor do low-GI foods cause a more steady or continued glucose reaction (Brand-Miller et 
al., 2009).   
A systemic review found a modest difference in glycemic control and 
cardiovascular risk when comparing low- and high-glycemic foods (Wheeler et al., 
2010).  This review suggests adherence to a lower-GI diet may produce a modest increase 
in glycemic control; however, some studies failed to acknowledge fiber (Wheeler et al., 
2010).  One study found an inverse association between GI and the risk for coronary 
heart disease in men. However, the participants were consuming large quantities of high-
fat milk. The researchers concluded that the type of fat replaced by the carbohydrate has a 
strong influence on coronary heart disease risk in this specific population, and the role of 
dietary fiber was also cited as an influence (Simila, Kontto, Mannisto, Valsta, & Virtamo, 
2013). Another review included a total of 15 studies; 12 were less than three months in 
duration and three were one year. Of the studies lasting one year, one reported the low-GI 
and control groups experienced no difference in GI (Wheeler et al., 2010), and the 
remaining two reported that low-GI and control groups had no difference in HbA1c 
values (MacLeod et al., 2017; Franz, et al., 2010).   There is also the question of 
individual irregularity of GI responses following carbohydrate consumption. It appears 
the majority of individuals with diabetes consume a medium-GI diet. Research remains 
inconclusive in determining if reduction in baseline GI consumption will produce 
improved glycemic control (Wheeler et al., 2010).  A 2017 study showed that following a 
high dietary fiber, low-glycemic index diet for six months significantly improved 
participants’ fasting plasma glucose and HbA1c levels (Cai, Wang, & Wang, 2017). 
Another study examined the effects of consuming a low-glycemic index and low-
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glycemic load diet as part of a hypo-caloric diet in type 2 diabetics (Argiana, Kanellos, & 
Makrilakis, 2015). After 12 weeks, body weight, BMI, and waist circumference were 
significantly reduced in both the control and intervention groups. Blood pressure, fasting 
blood glucose, HbA1c, and insulin were reduced significantly only in the intervention 
group. However, at the end point, there were no significant differences between the two 
groups (Argiana et al., 2015). As part of a randomized control trial, dietary recalls from 
238 Latino adults with type 2 diabetes were analyzed for glycemic index and glycemic 
load (Wang, Gellar, & Nathanson, 2015). Increases in glycemic index from baseline were 
associated with increases in HbA1c levels and waist circumference, but not with fasting 
blood glucose, blood lipid levels, or BMI (Wang et al., 2015). Independent of weight 
loss, two studies reported no significant effect on HbA1c levels in adults with type 2 
diabetes (Turner-McGrievy, Jenkins, & Barnard, 2011; Wolever, Gibbs, & Mehlin, 
2008). 
Fiber recommendations for individuals with diabetes do not differ from those for 
the general public (U.S. Department of Health and Human Services and U.S. Department 
of Agriculture, 2015). However, diets containing greater than 50 grams of fiber per day 
reportedly resulted in improved glycemic control in individuals with diabetes, while more 
common fiber consumption, roughly 24 grams per day, was not able to produce the same 
beneficial effect (Evert et al., 2013). Making half of all grains consumed whole grains 
remains one of the dietary recommendations for the general public and individuals with 
diabetes; however, whole grain consumption has not been shown to improve glycemic 
control (Evert et al., 2013). On the other hand, reduced incidence of type 2 diabetes has 
been associated with whole grain consumption in multiple cohort studies (ADA, 2012). 
	   	   	  
	  
21 
Carbohydrate Restriction  
 
Postprandial glycemia is predominantly altered by available insulin and the 
amount of carbohydrates rather than the type of carbohydrates consumed (Cefalu et al., 
2017; Evert et al., 2013; Franz et al., 2010). Therefore, the recommended approach for 
improving glycemic control is monitoring carbohydrate intake (Cefalu et al., 2017). This 
can be accomplished by counting carbohydrates or experienced approximation (Evert et 
al., 2013). Of course, carbohydrate intake from fruits, vegetables, whole grains, legumes, 
and dairy products should be emphasized over those containing added sugar, fat, or 
sodium (Evert et al., 2013).    
Comprehensive examination of the effects of low-carbohydrate diets on diabetes 
management is increasing as controversy continues to surround the search for an ideal 
diet to improve glycemic control (Tay, Luscombe-Marsh, & Thompson, 2015). A 
randomized control trial compared the effects of a very-low carbohydrate, high-
unsaturated fat, low-saturated fat diet with a high-carbohydrate, low-fat diet on glycemic 
control and cardiovascular risk factors after one year (Tay et al., 2015). Both diets 
produced significant weight loss and reduced HbA1c and fasting glucose. The low-
carbohydrate diet, which was high in unsaturated fat and low in saturated fat, showed 
greater improvements in the lipid profiles, blood glucose stability, and reductions in 
diabetes medication requirements, suggesting an effective strategy for the optimization of 
diabetes management (Tay et al., 2015). Additionally, a recent study demonstrated 
carbohydrate restriction produced significant HbA1c (8.9-8.25) and daily insulin use 
(64.4 to 44.2 units /day) reductions (Krebs, Parry, Strong, & Cresswell, 2016). When 
compared to traditional carbohydrate counting methods, no significant reductions in body 
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weight (83.2 to 78.0 kg) were shown (Krebs et al., 2016). Another study of the effects of 
a low-carbohydrate diet found that blood glucose control improved (HbA1c average 51 to 
40 mmol/mol), and only two of 19 participants remained with an abnormal HbA1c at the 
end of the study period. Average body weight was reduced from 100.2 kg to 91.0 kg, and 
average waist circumference decreased from 120.2 cm to 105.6 cm. Significant 
improvements in blood pressure and cholesterol were also observed (Unwin & Unwin, 
2014). One study found that individuals with type 2 diabetes improved glycemic control 
and lost more weight after being randomized to an online low-carbohydrate, ketogenic 
diet program when compared to a traditional, low-fat diabetic diet recommended by the 
ADA (Saslow et al., 2017).  Additionally, another recent study found a 6-month diet 
providing less than 130 grams of carbohydrates per day reduced HbA1c and BMI more 
than a calorie restricted diet. However, a one-year follow-up showed the benefits of the 
low-carbohydrate diet on BMI and HbA1c did not persist in comparison with the calorie-
restricted diet (Santo et al., 2017). Additional research is necessary to determine if a 
carbohydrate restricted diet can be effective in improving glycemic control, and to 
evaluate the effects in an outpatient setting. 
Non-Nutritive Sweeteners 
 
The use and consumption of non-nutritive sweeteners (NNS) has continued to be 
a controversial topic among both consumers and professionals (AHA and ADA, 2012). 
NNS are commonly referred to as non-caloric, low-calorie, or artificial sweeteners, and 
contain a greater concentration of intense sweet-taste than standard sweeteners, such as 
sucrose, while providing little to no energy (AHA and ADA, 2012). Both the ADA and 
the American Heart Association (AHA) state that consumers can use NNS approved by 
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the U.S. Food and Drug Administration (FDA) without a concern for safety (AHA and 
ADA, 2012). The FDA enforces a thorough approval process consisting of widespread 
studies that rigorously evaluate a product’s safety prior to use by consumers. With a 
plethora of misinformation circling the Internet, social media, and other news media, it is 
important for health care professionals to thoroughly evaluate the safety and consumption 
of NNS in order to assist in providing consumers with the proper recommendations 
regarding this controversial topic (AHA and ADA, 2012). 
In a 2010 review of recent literature, The Academy of Nutrition and Dietetics 
(AND) concluded that, generally, NNS do not have the ability to impact the glycemic 
response or lipid levels in individuals with diabetes. The possible effects of NNS intake 
seen in the research are likely attributed to the carbohydrate substitute of NNS rather than 
a direct result. AND also recommends individuals with diabetes use NNS as a means to 
manage their weight and better control blood glucose levels while also reducing sugar, 
fat, and carbohydrate intake (Academy of Nutrition and Dietetics Evidence Analysis 
Library, 2010).  
Recent publications have revealed the adverse effect NNS can have on blood 
glucose levels following a weeklong consumption of sucralose and saccharin (Klein, 
2013; Pepino, Tiemann, Patterson, & Wice, 2013; Suez, Korem, & Zeeevi, 2014). The 
research conducted by Pepino et al. showed increased insulin and C-peptide levels, and a 
decrease in insulin sensitivity following sucralose exposure. However, it is important to 
note the test population included a large percentage of obese individuals, with the average 
BMI being 42 kg/m2 (Pepino et al., 2013). In only seven subjects, Suez et al. studied the 
effects of saccharin intake after one week. Four of the seven subjects experienced a 
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significant increase in blood glucose levels. A fecal sample was taken from the 
individuals experiencing the increase in glucose concentrations. Their feces were 
transplanted to mice. Following the transplant, the mice also experienced an increase in 
blood glucose levels. These results suggest NNS intake may impact the intestinal 
microbiome, thus impairing glucose tolerance (Suez et al., 2014).  
GLP-1 concentrations have been studied. One study examined the effects of 
sucralose and acesulfame-K exposure, and found an increase in GLP-1 concentrations 
following exposure (Brown, Brown, Onken, & Beitz, 2012).  A second study also 
demonstrated an increase in GLP-1 concentration following sucralose consumption 
(Temizkan et al., 2015).  
Fats 
 
Individuals with diabetes have an increased risk for atherosclerotic 
cardiovascular, peripheral arterial, and cerebrovascular disease, as well as hypertension 
and lipoprotein metabolism abnormalities (ADA, 2014). The type of fat versus the 
amount of fat consumed is more important when focusing on metabolic goals and 
cardiovascular disease risk (Evert et al., 2013). Unsaturated fats are recommended over 
saturated or trans fats for individuals with diabetes as well as the general public (Evert et 
al., 2013). Limiting fat intake will also help individuals achieve weight goals (Evert et al., 
2013).  When monounsaturated fats were consumed in place of carbohydrates and/or 
saturated fats, improved glycemic control and/or lipid profiles were observed. 
Consumption of foods rich in monounsaturated fats is commonly associated with the 
Mediterranean-style diet. Although the general public and individuals with diabetes are 
advised to increase long-chain omega-3 fatty acid consumption, supplementation with 
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omega-3 fatty acids is not recommended for individuals with diabetes as a means for 
treatment or prevention of cardiovascular issues (Evert et al., 2013). A systemic review of 
seven randomized controlled trials suggested omega-3 supplementation failed to improve 
glycemic control or consistently affect serum cardiovascular risk markers (Wheeler et al., 
2010).  The results of a large six-year study of individuals with diabetes found one gram 
of omega-3 supplementation per day compared to placebo was unable to reduce the rate 
of cardiovascular events, death from arrhythmia, or all-cause death (Bosch et al., 2012). 
 Total fat, particularly saturated fat, has negative effects on insulin sensitivity in 
individuals with diabetes. Research suggests continued intake of diets high in total fat 
were associated with increased rates of insulin resistance (Estadella et al., 2013; Riserus, 
2008).  Improved insulin sensitivity has been achieved through reduction in saturated fat 
intake; however, research including individuals with diabetes is limited (Lee et al., 2006). 
As individuals with diabetes work towards controlling carbohydrate intake, fat intake 
commonly increased (Davis et al., 2009). Thus, monitoring long-term saturated fat intake 
becomes increasingly necessary due to the effects on insulin resistance (Davis et al., 
2009).  
 Researchers conducting a parallel design, randomized control trial in 141 
participants with type 2 diabetes found a low-glycemic load diet enriched with canola oil 
significantly improved HbA1c values and reduced cardiovascular disease risk factors 
when compared to the control group (Jenkins, Kendall, & Vuksan, 2014). Multiple 
studies have reported no significant effect of differing amounts of unsaturated and 
saturated fatty acids on HbA1c or glucose levels in adults with type 1 and type 2 diabetes 
(Delahanty, Nathan, & Lachin, 2008; Strychar, Cohn, & Renier, 2009; Wolever et al., 
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2008). One reported no significant effect on exogenous insulin doses in adults with type 1 
diabetes (Strychar et al., 2009), and one reported no significant effect on endogenous 
insulin levels in adults with type 2 diabetes (Wolever et al., 2008).  
 
Dietary Patterns and Diabetes Management 
 
 Dietary patterns are defined as combinations of various foods or food groups that 
describe associations between nutrition and disease (Cefalu et al., 2017). Diabetes can be 
managed by a variety of dietary patterns (Cefalu et al., 2017). Therefore, it is important to 
explore diet in terms of dietary patterns and food choices as opposed to studying single 
nutrients (Jones-McLean, Shatenstein, & Whiting, 2010). Evert et al. reviewed studies 
focused on eating patterns of individuals with diabetes to determine the effect of dietary 
patterns on diabetes nutrition goals (Evert et al., 2013). The following dietary patterns 
were reviewed: Dietary Approaches to Stop Hypertension (DASH); low-fat; low-
carbohydrate; vegetarian; and Mediterranean. The research revealed multiple dietary 
patterns may lead to improved glycemic control or cardiovascular risk, and no one dietary 
pattern is ideal for all individuals with diabetes (Wheeler et al., 2010).  
DASH Dietary Pattern 
 
The DASH diet promotes consumption of fruits, vegetables, low-fat dairy 
products, whole grains, poultry, fish, and nuts, while limiting saturated fat, red meat, 
added sugars, and sodium (Evert et al., 2013).  The DASH diet is commonly 
recommended for the general public, as it has been shown to improve blood pressure and 
cardiovascular risk factors in individuals without diabetes (Appel et al., 1997; Sacks et 
al., 2001; U.S. Department of Health and Human Services and U.S. Department of 
Agriculture, 2015). Research highlighting the effects of the DASH diet on outcomes in 
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individuals with diabetes is limited; however, the DASH diet has shown an improvement 
in glycemic control, blood pressure, and cardiovascular risk factors in individuals with 
diabetes (Azadbakht et al., 2011). The DASH diet also has been associated with lower 
risk of mortality (Park et al., 2016). 
Low-Fat Dietary Pattern  
 
The low-fat diet is characterized by a total fat intake less than 30% of total energy 
intake and less than 10% from saturated fat, while including fruits, vegetables, starches, 
lean protein, low-fat dairy products (Evert et al., 2013).  The Look AHEAD trial 
evaluated a calorie restricted, low-fat diet that produced significant weight loss (Pi-
Sunyer et al., 2007). However, multiple researchers suggest reduced fat intake was unable 
to consistently improve glycemic control or cardiovascular disease risk factors (Brehm et 
al., 2009; Davis et al., 2009; Guldbrand et al., 2012; Kodama et al., 2009; 
Papakonstantinou et al., 2010; Wheeler et al., 2010). When calorie restriction and weight 
loss occur, it appears the benefit from a low-fat diet is greater (Pi-Sunyer et al., 2007). 
Vegetarian Dietary Pattern 
 
Limiting animal products may reduce risk of chronic disease due to decreased 
saturated fat and cholesterol intake, and increased fruit, vegetable, whole grain, nut, soy, 
fiber, and phytochemical consumption (Evert et al., 2013). Of the six vegetarian and low-
fat vegan diet studies reviewed, glycemic control or cardiovascular disease risk was not 
consistently improved in individuals with diabetes unless calorie restriction and weight 
loss occurred (Barnard et al., 2006; Barnard et al., 2009; Kahleova et al., 2011; Nicholson 
et al., 1999; Tonstad, Butler, Yan, & Fraser, 2009; Turner-McGrievy et al., 2008). 
Weight loss with the vegetarian diet has occurred in most studies (Barnard et al., 2006; 
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Nicholson et al., 1999; Tonstad et al., 2009; Kahleova et al., 2011). One study showed 
that a vegetarian diet reduced subfascial fat and intramuscular fat more than a traditional 
hypocaloric diabetic diet in individuals with type 2 diabetes (Kahleova et al., 2017).  
Mediterranean Dietary Pattern 
 
The Mediterranean diet focuses on increased local, seasonal plant-based food 
intake, and limiting processed foods. The fat source of choice for this diet regimen is 
olive oil. Additional fats from dairy products are limited, while the consumption of eggs 
is no more than four per week. In addition, red meat is excluded from the diet, but wine is 
consumed with meals (Evert et al., 2013). Improvement of cardiovascular risk factors has 
been reported in multiple studies following the implementation of the Mediterranean diet 
in individuals with diabetes (Elhayany, Lustman, Abel, Attal- Singer, & Vinker, 2010; 
Esposito et al., 2009; Franz et al., 2010; Wheeler et al., 2010). One study reported a 
reduced rate of cardiovascular events and stroke when diets included nuts or olive oil 
(Estruch et al., 2013).  Improved glycemic control was observed in individuals following 
a calorie controlled, Mediterranean diet (Wheeler et al., 2010). However, most research 
studies were conducted in the Mediterranean region, which warrants the need for 
additional research to determine the ability to generalize findings to other populations 
(Evert et al., 2013). In a randomized trial of 215 adults with newly diagnosed type 2 
diabetes, the Mediterranean-style eating pattern resulted in a greater reduction of HbA1c 
levels, higher rate of diabetes remission, and delayed need for diabetes medication 
compared to the low-fat diet. The Mediterranean diet was composed of less than 50% of 
energy from carbohydrates and greater than 30% from fat, mainly from olive oil, while 
the low-fat diet was defined as less than 30% of energy from fat, and rich in whole grains 
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(Esposito, Maiorino, & Petrizzo, 2014). Additionally, the Mediterranean diet has been 
shown to reduce inflammatory activity in newly diagnosed type 2 diabetes, and 
demonstrated that ongoing inflammatory activity is associated with the need to initiate 




Given the prevalence of diabetes and the severity of complications associated 
with uncontrolled blood glucose levels, individuals with diabetes should receive diabetes 
medical nutrition therapy in addition to regular physical activity and if necessary, 
appropriate medication(s) (Academy of Nutrition and Dietetics, 2015; Cefalu et al., 2017; 
Evert et al., 2013; Franz et al., 2017). Medical nutrition therapy for diabetes management 
is effective in improving blood glucose control by using appropriate dietary strategies 
(Academy of Nutrition and Dietetics, 2015; Cefalu et al., 2017; Evert et al., 2013; Franz 
et al., 2017). In addition, weight loss generally occurs with patient compliance and 
enhances patient health outcomes (Bantle et al., 2008; Evert et al., 2013; Esposito et al., 
2009; Franz et al., 2010; Franz et al. 2013; Pi-Sunyer et al., 2007). Even though experts 
may not agree on the ideal diet regimen to control blood glucose levels, they do concur 
different diet patterns have been shown to improve glycemic control and reduce the risk 
of cardiovascular complications (Cefalu et al., 2017; Evert et al., 2013; Strychar, 2009). 
Individualized nutrition therapy goals should be goals the individual is willing and able to 
achieve (Cefalu et al., 2017; Evert et al., 2013; Wolever et al., 2008). Overall, the goal of 
diabetes medical nutrition therapy is to improve weight, glucose, lipid, and blood 
pressure. 
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The aim of this retrospective chart review was to evaluate the effectiveness of the 
BRG Fit! program by assessing the outcomes of patients who have participated in the 12-
hour outpatient diabetes management program focused on a low-glycemic index diet. The 
outcomes evaluated included changes in weight, BMI, triglycerides, cholesterol, and 
HbA1c values following participation in the program. The health outcomes one year 
following program participation were compared to baseline data of participants who met 




The subjects of this retrospective chart review consisted of individuals who 
participated in the 12-hours of the outpatient diabetes management program of Baton 
Rouge General Medical Center in Baton Rouge, Louisiana. Retrospective data from 
participants with type 2 diabetes were included. Study eligibility requirements included: 
participation in the BRG Fit! program; not pregnant; and at least 18 years of age. 
Participants with normal BMI (<25 kg/m2) and HbA1c (<6.5%) values were excluded. A 
total of 25 participants were excluded because they did not have type 2 diabetes; this 
included 12 participants with pre-diabetes, 1 with gestational diabetes, 10 with type 1 
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diabetes, and 2 with other conditions.  Participants also were excluded from the study if 
pre-/postintervention data were not available. Post-intervention data were obtained 




Researchers obtained anthropometric, biochemical, and demographic data from a 
password protected, electronic document containing de-identified data. Demographics 
obtained included age, gender, and self-reported race/ethnicity. Biochemical tests were 
ordered by the referring physician and reviewed by the RD and RN of the program. 
Trained healthcare professionals collected biochemical and anthropometric data. Pre-
intervention data were collected at the initial visit at the start of the program. Participants 
provided post-intervention data, which were collected at an annual follow-up 
appointment scheduled for one-year following participation in the program. All data were 
recorded in the electronic medical record by either the RN or RD of the program. Then, 





The Human Use Committee at Louisiana Tech University along with the 
Institutional Review Board at Baton Rouge General Medical Center approved this study 
before data collection was initiated (Appendix B). Upon approval from both parties 
involved, de-identified data of all individuals who participated in the program between 
January 2015 and April 2018 were delivered electronically to the researcher in a 
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password protected document accessible only by the researcher. All participants with 




Microsoft Excel, version 14, was used for data analyses. The primary purpose of 
the data analysis was to assess the change in anthropometric and biochemical outcomes 
in relation to diabetes management following program participation. Baseline data were 
compared to data collected at one-year follow-up post program participation using paired 
sample t-tests for continuous variables. T-tests also were used to test for differences in 
the changes in outcomes based on gender. Statistical significance was defined as a p-
value <0.05.  








The purpose of this study was to identify differences in weight, BMI, 
triglycerides, cholesterol levels, and hemoglobin A1c values following participation in a 
12-hour outpatient diabetes management program focused on using a low-glycemic index 
diet to control blood glucose levels. Health outcomes obtained one year following 
program participation were compared to baseline data obtained prior to beginning the 
program. Results were compared between male and female participants.  
A total of 414 participants participated in the program between January 2015 and 
April 2018, and 283 of those were included in this study. Participants were excluded for 
failing to provide baseline or follow-up data, which excluded 106 participants. A total of 
25 participants were excluded because they did not have type 2 diabetes; this included 12 
participants with pre-diabetes, 1 with gestational diabetes, 10 with type 1 diabetes, and 2 
with other conditions.   
Participants included 94 (33%) men and 189 (67%) women of several different 
racial backgrounds (64% African American), with a mean baseline HbA1c of 8.7% ±2.2. 
The average age of participants was 58 ± 11.2 years, with no significant difference 
between male and females. The demographics of the participants are further outlined in 
Table 1. 
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Table 1 
Low-Glycemic Index Diabetes Management Program Participant Demographics  
Variables Total (n 283) N(%) 
Male (n 94) 
N(%) 
Female (n 189) 
N(%) 
 
Age (years)     
18-29 5 (2) 1 (1) 4 (2) 
30-49 57 (20) 22 (23) 35 (18) 
50-64 137 (48) 47 (50) 90 (48) 
65+ 84 (30) 24(26) 60 (32) 
 
Race/ethnicity 
     African American 
     Caucasian  
     Hispanic 





















 Table 2 summarizes baseline data. The total group’s mean baseline health 
parameters were 228.1 lbs.±57.3 for weight; 37.5kg/m2 ±8.5 for BMI; 8.7% ±2.2 for 
HbA1c; 182.3 mg/dL ±47.8 for total cholesterol; 48.5 mg/dL ±14.7 for HDL cholesterol; 
102.9 mg/dL±40.1 for LDL cholesterol; and 169.3mg/dL±137.7 for triglycerides. Except 
for HbA1c and total cholesterol, there were statistically significant differences in the 
baseline health outcomes measured based on gender. Table 2 also provides a breakdown 
of baseline data based on gender. 
Clinical data collected following program participation are shown in Table 3. The 
total group’s mean follow-up data were 223.6lbs. ±55.2 for weight; 36.8kg/m2±8.2 for 
BMI; 7.6% ±1.9 for HbA1c; 170.0mg/dL ±42.5 for total cholesterol; 50.1mg/dL ±15.2 
for HDL cholesterol; 93.5mg/dL ±36.0 for LDL cholesterol; and 146.1mg/dL ±111.4 for 
triglycerides. Follow-up data based on gender are also shown in Table 3. 
 




Clinical Baseline Data For Program Participants 
Variables 
Total Males Females  
Mean±SD Mean±SD Mean±SD pvalue 
 
Weight (lbs) 228.1±57.3 241.3±54.6 221.5±57.6 
 
0.005 
BMI (kg/m2) 37.5±8.5 35.5±7.4 38.5±8.8 0.003 
Triglycerides (mg/dL) 169.3±137.7 218.7±200.5 144.7±82.0 0.001 
Total Cholesterol (mg/dL) 182.3±47.8 175.1±48.0 185.8±47.4 0.076 
HDL Cholesterol (mg/dL) 48.5±14.7 41.6±12.4 51.9±14.5 <0.001 
LDL Cholesterol (mg/dL) 102.9±40.1 94.7±35.3 107.1±41.8 0.01 
HbA1c (%) 8.7 ±2.2 8.8±2.1 8.7±2.3 0.776 
P < 0.05 
 
Table 3 
Clinical Follow-Up Data For Program Participants 













BMI (kg/m2) 36.8±8.2 34.8±7.2 37.7±8.6 
Triglycerides (mg/dL) 146.1±111.4 175.2±162.0 131.6±70.4 
Total Cholesterol (mg/dL) 170.0±42.5 160.7±40.3 174.7±42.9 
HDL Cholesterol (mg/dL) 50.1±15.2 43.3±12.7 53.5±15.3 
LDL Cholesterol (mg/dL) 93.5±36.0 85.9±31.1 97.3±37.7 
HbA1c (%) 7.6 ±1.9 7.8±2.2 7.5±1.8 




Three hypotheses were tested in this study. Hypothesis one stated there would be 
no significant difference in BMI, and weight between baseline data and the annual 
follow-up data of those with type 2 diabetes. The null hypothesis was rejected. 
Significant improvements were seen in participants’ weight and BMI following program 
participation, and are outlined in Table 4.   Mean weight of the total group was 
significantly reduced by 4.5 lbs. (± 11.9, p<0.05). Mean BMI was also significantly 
reduced by 0.7 kg/m2 (±2.0, p<0.05) following program participation. 
The second null hypothesis was there would be no significant difference in 
HbA1c values, cholesterol levels, and triglyceride levels between baseline data and 
the annual follow-up data of those with type 2 diabetes. This null hypothesis was rejected 
as well. Significant improvements were seen in participants’ HbA1c, cholesterol and 
triglyceride levels following program participation, and are outlined in Table 4. 
Significant reductions were seen in mean HbA1c (-1.1% ±1.9, p<0.05), total cholesterol 
(-12.2 mg/dL ±37.3, p<0.05), HDL cholesterol (+1.6 mg/dL ±9.5, p<0.05), LDL 
cholesterol (-9.5 mg/dL ±30.7, p<0.05), and triglyceride levels (-23.2 mg/dL ±123.0, 











Changes In Outcome Measures Following Participation In A Low-Glycemic Index  
Focused Diabetes Management Program In Participants 
Variables Difference±SD pvalue 
Weight (lbs)   











Total Cholesterol (mg/dL) 
 
-12.2±37.3 <0.001 
HDL Cholesterol (mg/dL) 
 
+1.6±9.5 0.005 
LDL Cholesterol (mg/dL) 
 -9.5±30.7 <0.001 
HbA1c (%)     
 -1.1±1.9 <0.001 
P < 0.05 
 
The third hypothesis was there would be no significant difference in the change 
in hemoglobin A1c values, cholesterol levels, and triglyceride levels from baseline to the 
end of the program between males and females. This hypothesis was accepted. Changes 
in outcome measures following program participation based on gender are further 











Changes In Outcome Measures Following Participation In A Low-Glycemic Index  
Focused Diabetes Management Program Based on Gender 
Variables 
        Males  Females 
Difference±SD Difference±SD pvalue 
 
Weight (lbs)       
 
-4.7 ±11.6 -4.4±12.0 0.859 
BMI (kg/m2) 
        
-0.7±1.8 -0.72±2.2 0.807 
Triglycerides (mg/dL) 
 
-43.5±192.0 -13.1±64.5 0.138 
Total Cholesterol (mg/dL 
 
-14.4±44.3 -11.1±33.3 0.533 
HDL Cholesterol (mg/dL) 
 
+1.7±8.1 +1.6±10.1 0.956 
LDL Cholesterol (mg/dL) 
 -8.8±32.9 -9.8±29.6 0.809 
HbA1c (%)     
 -1.0±2.0 -1.1±1.9 0.607 
P < 0.05 
 
Significant outcomes were observed in both male and female groups. For the 
female group, significant improvements were seen in all health parameters evaluated in 
this study. Although the male group produced improvements in HDL cholesterol, results 
were not significant. HDL cholesterol was improved by 1.7mg/dL ±8.1 (p =0.052) 
following program participation. The female group produced significant HDL cholesterol 
outcomes with an improvement of 1.6 mg/dL ±10.1 (p<0.05) following program 
participation.







The purpose of this study was to identify differences in weight, BMI, 
triglycerides, cholesterol levels, and hemoglobin A1c values following participation in a 
12-hour outpatient diabetes management program focused on using a low-glycemic index 
diet to control blood glucose levels. Health outcomes obtained one year following 
program participation were compared to baseline data obtained prior to beginning the 
program. Results were compared between male and female participants.  
This was a retrospective study designed to evaluate the effectiveness of the BRG 
Fit! diabetes management program. The diet component of this program is different from 
that of most diabetes management programs; BRG Fit! emphasizes a low-glycemic index 
diet rather than the traditional carbohydrate consistent diet. Baseline data collected at the 
beginning of the program was compared with follow-up data collected following program 
completion. This study was not a randomized controlled trial; results were not compared 
to a control or typical ADA diet group, and therefore the results of this study should be 
interpreted cautiously.  
Individuals with diabetes constantly make decisions involving self-management, 
including dietary choices, regular blood glucose testing, and medication administration; 
ultimately effecting the progression and management of this chronic disease. DSME 
programs provide individuals with diabetes a foundation for properly navigating these 
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decisions, and activities and have been shown to improve health outcomes  (Brunisholz, 
Briot, & Hamilton, 2014; Steinsbekk, Rygg, Lisulo, Rise, & Fretheim, 2012; Weaver, 
Hemmelgarn, & Rabi, 2014). DSME programs have been shown to improve HbA1c by as 
much as 1% in people with type 2 diabetes (Siminerio, Ruppert, Huber, & Toledo, 2014; 
Tshianang et al., 2012; Welch, Zagarins, Feinberg, & Garb, 2011). It is the position of the 
ADA that all individuals with diabetes receive DSME at diagnosis and as needed 
thereafter (ADA, 2019). Studies evaluating DSME programs that use a low-glycemic 
index diet are limited.  
In the current study, weight, HbA1c, and BMI were significantly improved 
compared to baseline data. Participants achieved a mean weight loss of 4.5 lbs. or 1.8%. 
This accounted for a reduction of 0.7 kg/m2 in BMI. Previous studies using similar diet 
plans reported comparable findings. One study found a ketogenic diet (≤20 grams of 
carbohydrates and no calorie restriction) was associated with a 2.4 kg/m2 reduction in 
BMI compared to a 2.7 kg/m2 reduction with a low-fat diet (<30% energy from fat, 10% 
from saturated fat, <300mg of cholesterol, and a 500-1000 calorie deficit) after 48 weeks 
in individuals with type 2 diabetes (Mayer et al, 2014).  A low-carbohydrate, high-fat diet 
plan similar to the paleo diet was to be associated with an average weight loss of 19.4 lbs. 
following three months of diet compliance from individuals with two or more features 
associated with metabolic syndrome (Unwin, Cuthbertson, Feinman, & Sprung, 2015). 
More recently a diet plan referred to as the ketogenic diet or KETO has gained popularity 
and has demonstrated a mean body mass reduction of 19.8 lbs. or 7.2% from baseline 
after 10 weeks in individuals with type 2 diabetes (McKenzie et al., 2017).  A 
randomized clinical trial found a nutritional ketosis diet produced a 12.1 lbs. compared to 
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5.7 lbs. weight loss with a typical ADA “create your plate” diet following 32-weeks of 
online intervention in overweight or obese individuals with type 2 diabetes or pre-
diabetes (Saslow et al., 2014).  An additional randomized controlled trial by Tay et al., 
(2015) achieved similar mean weight loss after 52 weeks; individuals with type 2 
diabetes achieved an average weight loss of 21.56 lbs. while on a very-low carbohydrate, 
high-unsaturated fat diet (14% energy as carbohydrates and less than <10% of saturated 
fat per day) compared to 22.22 lbs. with a high carbohydrate low-fat diet (53% energy as 
carbohydrates and less than <10% of saturated fat per day). This current study was 
associated with less weight loss than previous studies presented here; however, the 
weight loss achieved was significant.  
Collectively, these studies support the premise that weight loss is facilitated by 
calorie control. The recommended approach to sustainable, long-term weight loss is to 
eliminate 500 Calories from an individual’s total daily caloric consumption to promote 1-
2 lb. weight loss per week. Incorporating 30-60 minutes of cardio and resistance training 
exercise per day will enhance weight loss and preserve lean muscle mass (ADA, 2019). 
Moreover, the CDC indicates a weight loss of as little as 5 - 10 percent of total body 
weight has been associated with improvements in blood pressure, blood cholesterol, and 
blood sugars (CDC, 2018). The BRG Fit! program is accredited by the AADE and ADA, 
which requires the development of program and service goals, as well as documentation 
of at least one clinical outcome measure to evaluate the effectiveness of the educational 
intervention. BRG Fit! focuses on individualizing behavior goals for participants while 
working together with the RN and RD of the program. However, BRG Fit! also 
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encourages a weight loss of 5% initial body weight and achieving an HbA1c of less than 
7%, which aligns with national guidelines (ADA, 2019).  
Participants in this study achieved a 1.1% mean decrease in HbA1c. Previous 
studies found similar results. One study found a low-carbohydrate diet with ≤20 grams of 
carbohydrates and no calorie restriction was associated with decrease in HbA1c of 0.7% 
compared to a 0.2% increase on the low-fat diet with <30% energy from fat, 10% from 
saturated fat, <300mg of cholesterol, and a 500-1000 Calorie deficit after 48 weeks in 
individuals with type 2 diabetes (Mayer et al., 2014).  A low-carbohydrate, high-fat diet 
plan similar to the paleo diet was associated with a reduction in HbA1c of 3.1% 
following three months of diet compliance from individuals with two or more features 
associated with metabolic syndrome (Unwin et al., 2015). A 10-week program promoting 
adequate carbohydrate restriction to achieve nutritional ketosis achieved a 1.0% reduction 
in HbA1c from baseline in individuals with type 2 diabetes (McKenzie et al., 2017).  A 
randomized clinical trial studying overweight or obese individuals with type 2 diabetes or 
pre-diabetes found HbA1c to be unchanged in the traditional ADA diet, while HbA1c 
was decreased by 0.6% in the nutritional ketosis group (Saslow et al., 2014).  An 
additional randomized controlled trial comparing outcomes of a 52 week very-low 
carbohydrate, high-unsaturated fat diet with 14% energy as carbohydrates and less than 
<10% of saturated fat per day and a high carbohydrate low-fat diet with 53% energy as 
carbohydrates and less than <10% of saturated fat per day showed both groups achieved a 
1.0% reduction in HbA1c (Tay et al., 2015). The improvements in HbA1c of this study 
are very similar to or greater than that of previous studies.  
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In this current study, significant improvements also were achieved in total 
cholesterol (-12.3 mg/dL), HDL cholesterol (+1.6mg/dL), LDL cholesterol (-9.4 mg/dL), 
and triglyceride levels (-23.2 mg/dL) compared to baseline.  Previous studies examining 
similar diet programs in adults with type 2 diabetes produced similar results. One study 
also showed that a low-carbohydrate, high-fat dietary intervention similar to the paleo 
diet was associated with an average reduction in total cholesterol of 11.6 mg/dL in 
individuals with two or more features associated with metabolic syndrome (Unwin et al., 
2015). An additional randomized controlled trial compared the effects of a very-low-
carbohydrate, high-unsaturated fat diet and a high carbohydrate low-fat diet following 52 
weeks of diet compliance. Both groups achieved similar reductions in LDL cholesterol (-
3.87 mg/dL with a very-low-carbohydrate, high-unsaturated fat diet vs -7.73 mg/dL with 
a high carbohydrate low-fat diet). Compared with the high carbohydrate diet group, the 
low-carbohydrate diet group achieved greater mean reductions triglycerides (-35.43 
mg/dL vs -17.71mg/dL), and greater mean increases in HDL cholesterol (3.87 mg/dL vs 
2.32 mg/dL)  (Tay et al., 2015).  These results could be attributed to overall improvement 
in dietary and lifestyle choices including reducing refined carbohydrate consumption and 
sugar, and not solely attributed to the specific carbohydrate to fat ratio of the diet itself.  
In this current study, no statistically significant differences were found in the change in 
baseline outcome measures to the end of the program between males and females. 
However, it is important to not that there were statistically significant differences in the 
baseline health outcomes measured based on gender, except for HbA1c and total 
cholesterol. The males in this current study exhibited significantly improved cholesterol, 
weight, BMI, and HbA1c levels. Although the male group produced triglycerides 
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improvements, the results were not significant. The female group produced significant 
improvements in follow-up weight, BMI, HbA1c, cholesterol, and triglyceride levels 
compared to baseline.  The results show that participants following a low-glycemic index 
diet gained a variety of health benefits including lower HbA1c, body weight, BMI, 
cholesterol, and triglyceride levels.    
All of these studies evaluated unconventional diets that differ from the traditional 
diet for treatment of type 2 diabetes recommended by the ADA, and yet all were able to 
produce similar effects on health parameters. Low-carbohydrate and/or low-glycemic 
index diets typically recommend the consumption of lean meats, seafood, mono-
unsaturated fats, poly-unsaturated fats, and vegetables, which leads to a diet high in B 
vitamins, healthy fats, antioxidants, and fiber.  Collectively, these nutrients work together 
to promote increased satiety, better glucose control, and reduction in inflammation 
(ADA, 2019). Unfortunately, these diets can seem restrictive and may become 
monotonous. Also, there is concern for ketoacidosis (ADA, 2019). Additional research 
should be conducted to determine the safety of a low-carbohydrate diet for those with 
diabetes with close monitoring of blood glucose levels and the transition to a typical 
ADA diet consisting of 50% of energy from carbohydrates, 20% from protein, and 30% 
from fat. The results of this study provide additional support for the use of a low-
glycemic index diet in improved health outcomes in individuals with type 2 diabetes. 
Traditionally, a carbohydrate consistent diet has been supported as the primary diet for 
diabetes management. Further studies should be conducted to compare results to a control 
group participating in a carbohydrate consistent diet program and consider a larger 
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number of participants followed over a longer duration of time to determine whether 
positive health effects are sustained long-term. 
The results of this study will provide great benefit to Baton Rouge General 
Medical Center. The positive results of this study demonstrate BRG’s program success in 
managing diabetes. This success can be used to attract additional referrals and patient 
participation. Thereby increasing revenue and offering the hospital opportunities to 
enhance the medical services provided. These results also demonstrate the success of the 
BRG Fit’s program manager and staff in providing a viable transition to patients from 
inpatient care to outpatient care services, thereby enhancing the continuity of care and 
better disease management and prevention.  
This study’s results also provide insight into where improvement and 
development is needed. For example, HDL cholesterol was significantly improved in the 
female population, but not in the male population. This study’s results provide evidence 
that a low-glycemic diet can be an effective strategy for diabetes management. This 
evidence also could be used in the development of future standardized diabetes 
management strategies; however, further research is warranted.  
This study has several limitations. Participants were educated on a low-glycemic 
index diet; however, detailed dietary intake was not measured. Medications at baseline or 
follow-up were not analyzed. Amount and frequency of dietary education varied between 
participants based on insurance coverage and participants’ ability to attend group classes 
and one-on-one sessions. This study also had no control group with which to compare 
results. A larger randomized controlled trial with a multiple follow-ups over a longer 
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duration is needed to better understand the effects of a low-glycemic index diet on 
glycemic control, weight and lipid levels.   
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APPENDIX A 
 
































	  	   	  48 
A-1 DATA COLLECTION INSTRUMENT 
 
De-Identified data was provided via a password-protected electronic document.  
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APPENDIX B 
B-1 LETTER OF APPROVAL FROM HUC 
B-2 LETTER OF APPROVAL FROM BRG’S IRB
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